Rush University Medical Center's Changing the Game in Lung Cancer Treatment: Precision Medicine in 2020
Rush 2020 Update on IO in 1L NSCLC: Is Single Agent PD-1 Antibody the Best First Choice for High PD-L1? What CPIs Are Best Option for Sparing Chemo? How Applicable Is Pembro Mono in Low PD-L1?
Comments 0
Login to view comments.
Click here to Login
